Brookfield, CT, United States of America

Paul Woodcock

This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Company. Active years: 2013-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Woodcock. Retrieved from https://idiyas.com/inventor/paul-woodcock

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Paul Woodcock

Introduction

Paul Woodcock is an accomplished inventor based in Brookfield, CT (US). He holds two patents that showcase his expertise in pharmaceutical formulations. His work has contributed significantly to the field of chronotherapeutics and delayed release dosage forms.

Latest Patents

Woodcock's latest patents include "Chronotherapeutic Dosage Forms" and "Delayed Release Dosage Forms." The chronotherapeutic formulation comprises a core containing an active agent and a surfactant, along with a delayed release compression coating made from natural or synthetic gum. The delayed release formulation also features a core with an active agent and a similar delayed release compression coating.

Career Highlights

Throughout his career, Woodcock has worked with notable companies such as Penwest Pharmaceuticals Company and Endo Pharmaceuticals Inc. His experience in these organizations has allowed him to refine his skills and contribute to innovative pharmaceutical solutions.

Collaborations

Some of his coworkers include Anand R Baichwal and Raymond Higgins. Their collaboration has likely played a role in advancing the projects they have worked on together.

Conclusion

Paul Woodcock's contributions to pharmaceutical innovations through his patents reflect his dedication to improving drug delivery systems. His work continues to influence the field and enhance patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…